The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $125.61

Today's change-1.32 -1.04%
Updated April 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $125.61

Today's change-1.32 -1.04%
Updated April 27 4:01 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings crosses below 20-day moving average

Laboratory Corporation of America Holdings closed lower Monday, dropping (U.S.)$1.32 or 1.04% to (U.S.)$125.61 and crossing below its 20-day moving average. Over the last five days, shares are unchanged, but are currently 4.25% below its 52-week high. This security has outperformed the S&P 500 by 13.08% during the last year.

Key company metrics

  • Open(U.S.) $128.00
  • Previous close(U.S.) $126.93
  • High(U.S.) $129.33
  • Low(U.S.) $125.13
  • Bid / Ask-- / --
  • YTD % change+16.41%
  • Volume1,703,743
  • Average volume (10-day)977,556
  • Average volume (1-month)827,971
  • Average volume (3-month)1,119,319
  • 52-week range(U.S.) $95.12 to (U.S.) $131.19
  • Beta0.61
  • Trailing P/E21.23×
  • P/E 1 year forward16.39×
  • Forward PEG1.84×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.92
Updated April 27 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.53%

Based on its net profit margin of 8.53%, Laboratory Corporation of America Holdings is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.42%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue1,5131,5521,5161,431
Total other revenue--------
Total revenue1,5131,5521,5161,431
Gross profit547571569517
Total cost of revenue966981948914
Total operating expense1,2941,3101,2701,227
Selling / general / administrative310306298285
Research & development--------
Depreciation / amortization15182221
Interest expense (income), net operating--------
Unusual expense (income)2628
Other operating expenses, total--------
Operating income219241247203
Interest income (expense), net non-operating-32-26-26-26
Gain (loss) on sale of assets--------
Other--------
Income before tax188219233188
Income after tax120138142114
Income tax, total68829174
Net income120137141113
Total adjustments to net income--------
Net income before extra. items120137141113
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items120137141113
Inc. avail. to common incl. extra. items120137141113
Diluted net income120137141113
Dilution adjustment0--00
Diluted weighted average shares86878687
Diluted EPS excluding extraordinary itemsvalue per share1.391.591.641.31
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.401.631.651.36